Breast and Ovarian Cancer Susceptibility Gene Testing, Prophylactic Mastectomy, and Prophylactic Oophorectomy — CPB 0227 | AETNA Coverage Update

Aetna modified CPB 0227 covering BRCA-related genetic testing, prophylactic mastectomy, and prophylactic oophorectomy, effective September 26, 2025. Here's what billing teams need to do.

Aetna, a CVS Health company, updated Clinical Policy Bulletin 0227 to address coverage for breast and ovarian cancer susceptibility gene testing alongside prophylactic surgical procedures. This policy governs over 260 CPT codes—including genetic testing codes like 0102U and 0172U, mastectomy codes 19303 and 19301, and hysterectomy/oophorectomy procedures across the 58150–58214 range. If your practice bills BRCA-related testing or risk-reducing surgery for Aetna members, this coverage policy change affects your reimbursement and prior authorization workflows starting September 26, 2025.

Quick-Reference Table

Aetna BRCA Testing and Prophylactic Surgery Coverage Criteria and Medical Necessity Requirements 2025

CPB 0227 Aetna system covers genetic testing, prophylactic mastectomy, and prophylactic oophorectomy when specific medical necessity criteria are met. The real issue here is that each service type carries its own criteria. Passing the wrong criteria set to a claim is the fastest path to a claim denial.

For genetic testing codes like 0102U, 0135U, and 0172U, Aetna evaluates whether the member has a personal or family history that puts them at elevated risk for hereditary breast or ovarian cancer. Testing is covered when selection criteria are met—meaning your documentation must reflect the clinical picture that triggered the order, not just a physician preference.

Prophylactic mastectomy (CPT 19303) and partial mastectomy (CPT 19301) fall under a similar standard. Medical necessity must be established through documented BRCA1 or BRCA2 pathogenic variant status, or comparable high-risk findings. Breast reconstruction codes—19350, 19357, 19361, 19364, 19366, 19367, 19368, and 19369—are also covered when selection criteria are satisfied.

The prophylactic oophorectomy and hysterectomy side of this policy is significant. Codes across the 58150–58214 range carry the same conditional coverage structure. Without the right clinical documentation tied to BRCA status or a comparable hereditary cancer syndrome, these claims will not clear medical necessity review.

Prior authorization is a real consideration here. Risk-reducing surgeries for BRCA carriers routinely require prior auth with Aetna. Confirm your prior authorization workflow covers the full code range before you submit. If your team isn't already building PA requests around documented genetic test results, start there.

Whether BRCA genetic testing is covered under Aetna's plan depends on the member's benefit design and whether clinical criteria align with the policy. Some self-funded employer plans exclude genetic testing services outright. Check member benefits before scheduling.

Aetna BRCA Testing and Prophylactic Surgery Exclusions and Non-Covered Indications

The policy's conditional coverage structure means that services are covered or not based on whether criteria are met—not automatically covered because the code exists. Genetic testing ordered without appropriate personal or family history documentation will not meet medical necessity. That's not ambiguous. That's a denial.

Somatic mutation testing via 0172U (BRCA1 somatic analysis for solid tumors) occupies a different clinical lane than germline testing. If your team submits germline-oriented criteria to justify a somatic test, expect a medical necessity denial.

Proprietary lab analysis (PLA) codes like 0102U and 0135U are tied to specific lab platforms. These codes are not interchangeable with standard BRCA sequencing CPT codes. Submit the wrong code for the lab performing the test and you'll face both a coding error and a coverage dispute.

Coverage Indications at a Glance

Aetna BRCA Testing and Prophylactic Surgery Billing Guidelines and Action Items 2025

Aetna genetic testing and prophylactic surgery billing requires precise documentation alignment. Generic orders won't survive a medical necessity audit. Here's what to do before the September 26, 2025 effective date.

CPT, HCPCS, and ICD-10 Codes for BRCA Testing and Prophylactic Surgery Under CPB 0227

Covered CPT Codes (When Selection Criteria Are Met)

Note: The full policy lists 260 CPT codes. The codes above represent the primary billing codes across the genetic testing, mastectomy, reconstruction, and gynecologic surgery categories. Pull the full code list from the policy source at app.payerpolicy.org/p/aetna/0227 before updating your charge master.

Key ICD-10-CM Diagnosis Codes

The policy includes 185 ICD-10-CM codes. The full diagnosis code list is available in the policy source. Your ICD-10 codes must reflect the clinical basis for each service—BRCA mutation status, personal cancer history, or documented hereditary cancer syndrome. Mismatched diagnosis codes are a primary driver of claim denial under this policy.